PHARMACY

FDA OKs third Lenvima indication
Eisai and Merck's third approved indication for Lenvima is for the first-line treatment of patients with unresectable hepatocellular carcinoma.
Hy-Vee pharmacies are set to give flu vaccines in store and corporate locations
Hy-Vee is stocked with flu vaccines in more than 250 of its pharmacy locations, and it is offering corporate flu clinics.

Walgreens, VA partner to improve care coordination

Through the partnership, Dept. of Veterans Affairs providers will be able to see the entire medication and immunization history of the VA-enrolled patient, if they receive prescriptions and immunizations at Walgreens.
Regeneron gets FDA nod for updated Eylea label

Regeneron Pharmaceuticals has received the green light from the Food and Drug Administration for a supplemental Biologics License Application for Eylea (aflibercept) injection in patients with wet age-related macular degeneration, or wet AMD).
Novadoz Pharmaceuticals to launch first 3 U.S. generics

Novadoz's generics of Crestor, Avelox and Xeloda were approved by the Food and Drug Administration in the fall of 2017.
Ironshore Pharmaceuticals gets FDA nod for Jornay PM for ADHD

Ironshore’s Jornay PM is approved for children 6 years and older who have ADHD.
Teva gets FDA clearance for first EpiPen generics

Teva will market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths.
Sun Pharma gets FDA nod for Cequa's dry eye treatment

Sun Pharma’s Cequa (cyclosporine ophthalmic solution) 0.09% for topical ophthalmic use combines cyclosporine A with nanomicellar technology, the company said.
OptumRx unveils sustainable medication packaging

OptumRx is replacing polystyrene, or foam, packaging with 100% renewable cotton medication packaging that is recyclable for its home delivery patients.
Hikma adds generics sales, marketing EVP

Kristy Ronco will lead Hikma's generics’ retail sales, addiction therapy sales, and branded sales teams.